We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Electronics-Enhanced Microfluidic Chip Counts and Characterizes Cells or Particles

By LabMedica International staff writers
Posted on 02 May 2016
In a proof-of-concept study, a team of electrical and computer engineers demonstrated the ability of an electronics-enhanced microfluidic chip to characterize and count ovarian cancer cells.

While numerous biophysical and biochemical assays have been developed that rely on spatial manipulation of particles or cells as they are processed on lab-on-a-chip devices, analysis of spatially distributed particles on these devices typically requires microscopy, which negates the cost and size advantages of microfluidic assays.

Investigators at the Georgia Institute of Technology (Atlanta, USA) have combined microfluidics with electronic sensor technology to produce a lab-on-a-chip device that can determine the location, size, and speed of cells moving through the microfluidic channels. More...
The information for each individual cell is stored and then used as the basis for automated cell counting and analysis.

The underlying principle enabling cell identification is code division multiple access (CDMA), which is used by cellular telephone networks to separate the signals from each user. The innovative on-chip version is called microfluidic CODES. The CODES method relies on a grid of micron-scale electrical circuitry located in a layer beneath the four-channel microfluidic chip. Current flowing through the circuitry creates an electrical field in the microfluidic channels above the grid. When a cell passes through one of the microfluidic channels, it creates an impedance change in the circuitry that signals the cell’s passage and provides information about the cell’s location, size, and the speed at which it is moving through the channel. The packet of information generated for each cell is assigned a unique seven-bit identifier number that is stored for analysis.

As a proof of principle, the investigators use this technology to detect human ovarian cancer cells in four different microfluidic channels fabricated using soft lithography. In this exercise more than a thousand ovarian cancer cells were tracked with an accuracy rate of better than 90%.

“We are digitizing information about the sorting done on a microfluidic chip,” said senior author Dr. Fatih Sarioglu, assistant professor of electrical and computer engineering at the Georgia Institute of Technology. “By combining microfluidics, electronics, and telecommunications principles, we believe this will help address a significant challenge on the output side of lab-on-a-chip technology.”

“We have created an electronic sensor without any active components,” said Dr. Sarioglu. “It is just a layer of metal, cleverly patterned. The cells and the metallic layer work together to generate digital signals in the same way that cellular telephone networks keep track of each caller’s identity. We are creating the equivalent of a cell phone network on a microfluidic chip. Our technique could turn all of the microfluidic manipulations that are happening on the chip into quantitative data related to diagnostic measurements.”

The CODES-based lab-on-a-chip was described in the March 29, 2016, online edition of the journal Lab on a Chip.

Related Links:
Georgia Institute of Technology


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new study aims to enhance colorectal cancer prevention by identifying polyp molecular signals (Photo courtesy of Shutterstock)

RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous

Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.